Efficacy and cost of peripheral blood stem cell (PBSC) mobilization with low-dose cyclophosphamide (LD-CY) compared with plerixafor (P) in multiple myeloma (MM) patients (pts) treated with novel induction therapies.
Lubna Chaudhary
No relevant relationships to disclose
Farrukh Tauseef Awan
No relevant relationships to disclose
Aaron Cumpston
No relevant relationships to disclose
William W. Tse
No relevant relationships to disclose
Michael Craig
No relevant relationships to disclose
Mehdi Hamadani
No relevant relationships to disclose